Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells

Kidney International

Volumn 46, Issue 4, 1994, Pages 1059-1068

  Rovin, Brad H ^a,b   Tan, Laura C ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CHEMOATTRACTANT; DIACYLGLYCEROL; DIBROMO CYCLIC AMP; ENZYME INHIBITOR; GENISTEIN; HERBIMYCIN A; INTERLEUKIN 1; PHORBOL ESTER; PROTEIN KINASE; TYRPHOSTIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESANGIUM CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 0027949106     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1994.367     Document Type: Article

References (51)

1. ROVIN BH, SCHREINER GF: Cell-mediated immunity in glomerular disease. Annu Rev Med 42:25-33, 1991
2. SEDOR JR, NAKAZATO Y, KONIECZKOWSKI M: Interleukin-1 and the mesangial cell. Kidney Int 41:595-599, 1992
3. ROVIN BH, YOSHIUMURA T, TAN L: Cytokine induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148:2148-2153, 1992
4. ZOJA C, WANG JM, BETTONI S, SIRONI M, RENZI D, CHIAKFARINO F, ABBOUD HE, VAN DAMME J, MANTOVANI A, REMUZZI G, RAMBALDI A: Interleukin-1β and tumor necrosis factor-α induce gene production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol 138:991-1003, 1991
5. SHYY Y-J, LI Y-S, KOLATTUKUDY PE: Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem Biophys Res Comm 169:346-351, 1990
6. SHYY Y-J, LI Y-S, KOLATTUKUDY PE: Activation of MCP-1 gene expression is mediated through multiple signaling pathways. Biochem Biophys Res Comm 192:693-699, 1993
7. VILLIGER PM, TERKELTAUB R, LOTZ M: Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 149:722-727, 1992
8. GHOSH S, BALTIMORE D: Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678-682, 1990
9. SHIRAKAWA F, MIZEL SB: In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol 9:2424-2430, 1989
10. LEE TH, LEE GW, ZIFF EB, VILCEK J: Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol 10:1982-1988, 1990
11. SHIRAKAWA F, YAMASHITA U, CHEDID M, MIZEL SB: Cyclic AMP - an intracellular second messenger for interleukin 1. Proc Natl Acad Sci USA 85:8201-8205, 1988
12. ROSOFF PM, SAVAGE N, DINARELLO CA: Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 54:73-81, 1988
13. KRACHT M, HEINER A, RESCH K, SZAMEL M: Interleukin-1-induced signaling in T-cells. J Biol Chem 268:21066-21072, 1993
14. O'NEILL LAJ: How does interleukin-1 activate cells? Kidney Int 41:546-549, 1992
15. PFEILSCHIFTER J, LEIGHTON J, PIGNAT W, MARKI F, VOSBECK K: Cyclic AMP mimics, but does not mediate, interleukin-1 and tumor necrosis factor-stimulated phospholipase A2 secretion from rat mesangial cells. Biochem J 273:199-204, 1991
16. KESTER M, MUSIAL AM: Mesangial cell signaling pathways for endothelin and interleukin-1.- Role of ether and ester-linked diglycerides. (abstract) J Am Soc Nephrol 3:497A, 1992
17. GUY GR, CHUA SP, WONG NS, S.B. N, TAN YH: Interleukin 1 and tumor necrosis factor activate common multiple protein kinases in human fibroblasts. J Biol Chem 266:14343-14352, 1991
18. LOVETT DH, MARTIN M, BURSTEN S, SZAMEL M, GEMSA D, RESCH K: Interleukin 1 and the glomerular mesangium. III. IL-1-dependent stimulation of mesangial cell protein kinase activity. Kidney Int 34:26-35, 1988
19. TAMAOKI T: Use and specificity of staurosporin, UCN-01, and Calphostin C as protein kinase inhibitors. Meth Enzymol 210:340-347, 1991
20. HAVERSTICK DM, GRAY LS: Lymphocyte adhesion mediated by lymphocyte function-associated antigen-1: I. Long term augmentation by transient increases in intracellular cAMP. J Immunol 149:389-396, 1992
21. CHIJIWA T, MISHIMA A, HAGIWARA M, SANO M, HAYASHI K, INOUE T, NAITO K, TOSHIOKA T, HIDAKA H: Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent portein kinase, N-(2-(p-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272, 1990
22. RIABOWOL KT, FINK JS, GILMAN MZ, WALSH DA, GOODMAN RH, FERAMISCO JR: The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature 336:83-86, 1988
23. MONTMINY MR: Regulation of cAMP-inducible genes by CREB. Trends in Neuro Sci 13:184-188, 1990
24. ROESLER WJ, VANDENBARK GR, HANSON RW: Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 263:9063-9066, 1988
25. BEEBE SJ, BLACKMORE PF, CHRISMAN TD, CORBIN JD: Use of synergistic pairs of site-selective cAMP analogs in intact cells. Meth Enzymol 159:118-159, 1988
26. AKIYAMA T, OGAWARA H: Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Meth Enzymol 210:362-370, 1991
27. UEHARA Y, FUKAZAWA H: Use and selectivity of herbimycin A as an inhibitor of protein-tyrosine kinases. Meth Enzymol 210:370-379, 1991
28. LEVITZKI A, GAZIT A, OSHEROV N, POSNER I, GILON C: Inhibition of protein-tyrosine kinases by tyrphostins. Meth Enzymol 201:347-361, 1991
29. GAZIT A, OSHEROV N, POSNER I, YAISH P, PORADOSU E, GILON C, LEVITZKI A: Tyrphostins. 2. Heterocyclic and α-substituted benzylidenemalonoitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J Med Chem 34:1896-1907, 1991
30. FALK W, GOODWIN RH, LEONARD EJ: A 48 well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Meth 33:239-247, 1980
31. GRAZIANO RF, FANGER MW: Human monocyte-mediated cytotoxicity: The use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocyte cell surface. J Immunol 138:945-950, 1987
32. EVANOFF HL, BURDICK MD, MOORE SA, KUNKEL SL, STRIETER RM: A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol Invest 21:39-45, 1992
33. BARKER JNWN, JONES ML, SWENSON CL, SARMA V, MITRA RS, WARD PA, JOHNSON KJ, FANTONE JC, DIXIT VM, NICKOLOFF BJ: Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN. J Immunol 146:1192-1197, 1991
34. JIANG Y, TABAK LA, VALENTE AJ, GRAVES DT: Initial characterization of the carbohydrate structure of MCP-1. Biochem Biophys Res Comm 178:1400-1404, 1991
35. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by quanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
36. ROLLINS BJ, STIER P, ERNST T, WONG GG: The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 9:4687-4695, 1989
37. FEINBERG AP, VOGELSTEIN B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
38. KYHSE-ANDERSEN J: Electroblotting of multiple gels: A simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Meth 10:203-209, 1984
39. DONG Z, O'BRIAN CA, FIDLER IJ: Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J Leuk Biol 53:53-60, 1993
40. NAHMAN NS, ROVIN B, LEONHART K: Protein kinases modulate fibronectin production by human mesangial cells. (abstract) J Am Soc Nephrol 4:660, 1993
41. COSIO FG, ROVIN BH: Complement induction of decay accelerating factor on human mesangial cells: Signal transduction pathways. (abstract) J Am Soc Nephrol 4:598, 1993
42. VALENTE AJ, ROZEK MM, SCHWARTZ CJ, GRAVES DT: Characterization of monocyte chemotactic protein-1 binding to human monocytes. Biochem Biophys Res Comm 176:309-314, 1991
43. SKOGLUND G: Selective inhibition by H7 and staurosporin of phorbol ester responses in U-937 cells. Cell Signalling 5:325-330, 1993
44. MIZUNO K, SAIDO TC, OHNO S, TAMAOKI T, SUZUKI K: Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC. FEBS Lett 330:114-116, 1993
45. BOUVIER M, COLLINS S, O'DOWD BF, CAMPBELL PT, BLASI A, KOBILKA BK, MACGREGOR C, IRONS GP, CARON MG, LEFKOWITZ RJ: Two Distinct Pathways for cAMP-mediated down-regulation of the β2-adrenergic receptor. J Biol Chem 264:16786-16792, 1989
46. DANIEL TO, FEN Z: Distinct pathways mediate transcriptional regulation of platelet-derived growth factor B/c-sis expression. J Biol Chem 263:19815-19820, 1988
47. BERGONZELLI GE, KRUITHOF EK, MEDCALF RL: Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3′,5′-monophosphate. Endocrinology 131:1467-1472, 1992
48. SATRIANO JA, HORA K, SHAN Z, STANLEY ER, MORI T, SCHLONDORFF D: Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-γ, tumor necrosis factor-α, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150:1971-1978, 1993
49. BLENIS J: Growth-regulated signal transduction by the MAP kinases and RSKs. Cancer Cells 3:445-449, 1991
50. DAVIS RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556, 1993
51. BIRD TA, SCHULE HD, DELANEY PB, SIMS JE, THOMA B, DOWER SK: Evidence that MAP (mitogen-activated protein) kinase activation may be a necessary but not sufficient signal for a restricted subset of responses in IL-1-treated epidermoid cells. Cytokine 4:429-440, 1992